United Therapeutics (UTHR)

Add to Watchlists
Create an Alert
96.97 +0.86  +0.89% NASDAQ Apr 16, 9:37AM BATS Real time Currency in USD

United Therapeutics Research and Development Expense (Quarterly):

121.55M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

United Therapeutics Research and Development Expense (Quarterly) Chart

Pro Export Data
Pro Save Image

United Therapeutics Historical Research and Development Expense (Quarterly) Data

Pro Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 121.55M
Sept. 30, 2013 72.75M
June 30, 2013 54.62M
March 31, 2013 50.43M
Dec. 31, 2012 37.48M
Sept. 30, 2012 65.16M
June 30, 2012 37.10M
March 31, 2012 33.66M
Dec. 31, 2011 48.64M
Sept. 30, 2011 59.43M
June 30, 2011 24.24M
March 31, 2011 47.71M
Dec. 31, 2010 61.92M
Sept. 30, 2010 40.34M
June 30, 2010 28.59M
March 31, 2010 34.87M
Dec. 31, 2009 41.03M
Sept. 30, 2009 31.55M
June 30, 2009 28.65M
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro
Sept. 30, 2008 Go Pro
June 30, 2008 Go Pro
March 31, 2008 Go Pro
Dec. 31, 2007 Go Pro
   
Sept. 30, 2007 Go Pro
June 30, 2007 Go Pro
March 31, 2007 Go Pro
Dec. 31, 2006 Go Pro
Sept. 30, 2006 Go Pro
June 30, 2006 Go Pro
March 31, 2006 Go Pro
Dec. 31, 2005 Go Pro
Sept. 30, 2005 Go Pro
June 30, 2005 Go Pro
March 31, 2005 Go Pro
Dec. 31, 2004 Go Pro
Sept. 30, 2004 Go Pro
June 30, 2004 Go Pro
March 31, 2004 Go Pro
Dec. 31, 2003 Go Pro
Sept. 30, 2003 Go Pro
June 30, 2003 Go Pro
March 31, 2003 Go Pro
Dec. 31, 2002 Go Pro
Sept. 30, 2002 Go Pro
June 30, 2002 Go Pro
March 31, 2002 Go Pro
Dec. 31, 2001 Go Pro
Sept. 30, 2001 Go Pro

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

UTHR Research and Development Expense (Quarterly) Benchmarks

Companies
Pluristem Therapeutic 6.107M
Siga Technologies 2.819M
Actelion 104.21M

UTHR Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 24.24M Jun 2011
Maximum 121.55M Dec 2013
Average 48.40M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.